Global Cannabis expands supply chain in Europe through agreement with Complete Cannabis Technologies
SAN DIEGO, CA, Sept. 08, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical marijuana, Inc. (OTC: MJNA) (“the Company”), the first publicly traded cannabis company in the United States that launched the world’s first cannabis-derived products, brands, and supply chain, today announced that its subsidiary, Kannaway, has signed a distribution agreement with long-term partner Complete Hemp Technologies. (CHT) to expand its capabilities in the European market. The agreement adds warehousing and day-to-day operations to services CHT already provides to Kannaway in Europe, providing cost savings and improvements to gross margins in one of the company’s largest international markets.
The company has worked with CHT for years to facilitate expansion across Europe, leveraging its strong relationships with regulators and industry-leading cannabis-based product capabilities. CHT will now provide distribution services eliminating the need for product transportation after manufacture as well as financing additional warehouse space and associated labor costs.
“As the first US company to enter Europe with our cannabis-based products, we have built long-standing relationships with the most experienced companies in the region and this agreement is a perfect example of that,” said Blake Schroeder, CEO of Medical Marijuana. “It’s a win-win for both companies. We will continue to leverage our superior product formulations and brand equity as the original trusted source for quality products, while being backed by a reputable company with a proven track record for success.”
“We are excited to continue working with Medical Marijuana, Inc. and its family of companies,” said Rafal Modlinski, CEO of Complete Hemp Technologies. “Their dedication to creating and distributing high-quality products on a global basis is perfectly aligned with our vision here at CHT. With this agreement, we will be able to expand the reach and reach of Medical Marijuana, Inc. and Kannaway products.”
About Medical Marijuana, Inc.:
We are Firsts®. Medical marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabis space: a global group of hemp-based nutritional brands led by Kanawee® And HempMeds®; leader in sourcing high quality, legal, non-psychoactive cannabis products derived from industrial hemp; and the cannabis-based clinical research and plant-based drug development segment led by pharmaceutical investment firms and their partners incl AXIM® Biotechnologies, Inc. And Neurobatics. Medical Marijuana, Inc. As the best CBD product by CNBC. Medical Marijuana, Inc. Also the first company to obtain historical import authorizations for CBD products from the governments of Brazil, Mexico, Argentina and Paraguay and is a leader in the development of international markets. The company’s main product Real scientific hemp oil It has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.
Medical Marijuana, Inc. is headquartered in In San Diego, California, additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. Watch the Medical Marijuana, Inc. video. , click here.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934, and is subject to the safe harbor laws established by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and are subject to risks and uncertainties. These forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to differ. substantially from the data presented here.
Disclosure from the Food and Drug Administration (FDA):
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Medical Marijuana, Inc. does not sell or distribute any products that violate the US Controlled Substances Act.
Investor Relations Contact:
P. (858) 283-4016